Stay Updated with the Latest Cassiopea S.p.A. SKIN.SW News in Real Time
Find SKIN.SW news now at Meyka AI. Stay informed with the latest Cassiopea S.p.A. stocks updates, including price news, market analysis, and expert insights.
France Shooting in Trappes: What We Know About the “Racist Terrorist Attack”
The France shooting that shook Trappes, a town south-west of Paris, on Friday 23 October 2026 has been described by President Emmanuel Macron as a “terrorist and racist attack”. One person was killed and five others were injured after a gunman opened fire from his car in a rampage that lasted around 15 minutes, targeting…
Melbourne Firebombing Crisis: 13-Year-Old in Critical Condition, Three Teens Arrested
A 13-year-old boy fights for his life after suffering 90% burns in a Melbourne firebombing. Three teenagers arrested. Police link attacks to organised crime recruiting youth online.
Florida Declares Dengue Emergency as First Death Confirmed, Cases Hit 152
Florida confirms first dengue death and declares emergency as outbreak reaches 152 cases. Hillsborough County hit hardest with 134 cases. What residents need to know.
Korea Finds Banned Chemicals in Popular Squishy Toys; 8 Products Unsafe
Korea Consumer Agency found banned preservatives and phthalates in squishy stress toys. All 8 wax puff balls contained banned chemicals; one toy had plasticizers at 6.6 times the safety limit.
Victorian Toddler Dies After Petting Zoo E. Coli Infection, September 2
Three-year-old dies from E. coli infection contracted at Victorian petting zoo after six weeks in hospital with kidney failure and brain damage.
Australia’s Diphtheria Outbreak Hits 538 Cases, Largest Since 1991
Australia records 538 diphtheria cases in 2026, the largest outbreak since national reporting began in 1991. Cases concentrated in Northern Territory and Western Australia among Aboriginal communities.
Australia’s diphtheria outbreak hits 530 cases, largest since 1991
Australia records 530 diphtheria cases in largest outbreak since 1991, with cases concentrated in Northern Territory and Western Australia. Health experts warn actual numbers may be higher due to inconsistent testing.
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20
Moderna jumps 177% and Merck rises 12% after their mRNA cancer vaccine meets Phase 3 endpoints for melanoma. The combo reduced cancer recurrence and spread in over 1,100 patients.
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.